Clinical Trials Logo

Filter by:
NCT ID: NCT00378495 Terminated - Kala Azar Clinical Trials

Miltefosine for Brazilian Visceral Leishmaniasis

Start date: April 2005
Phase: Phase 1/Phase 2
Study type: Interventional

Miltefosine will be administered to Brazilian patients with kala azar

NCT ID: NCT00376493 Terminated - Septic Abortion Clinical Trials

Prolonged Treatment for Infected Abortion After Hospital Discharge.

APA
Start date: May 2006
Phase: Phase 4
Study type: Interventional

Patients with infected abortion will be treated with dilatation and curettage, intravenous antibiotics. The purpose of this study is to verify if it is necessary to keep the use of oral antibiotics after hospital discharge.

NCT ID: NCT00376337 Terminated - Clinical trials for Invasive Aspergillosis

Micafungin Salvage Mono-therapy in Invasive Aspergillosis

Start date: June 2006
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy and safety of micafungin in patients with proven invasive aspergillosis and who are refractory or intolerant to previous systemic antifungal therapy. To compare the efficacy and safety of the micafungin therapy with the active control arm

NCT ID: NCT00373113 Terminated - Breast Neoplasms Clinical Trials

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine

Start date: November 2006
Phase: Phase 3
Study type: Interventional

To compare efficacy and safety of Sunitinib and Capecitabine in subjects with advanced breast cancer who failed both a taxane and an anthracycline chemotherapy regimen or failed with a taxane and for whom further anthracycline therapy is not indicated

NCT ID: NCT00372996 Terminated - Breast Neoplasms Clinical Trials

Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer

Start date: February 2007
Phase: Phase 2
Study type: Interventional

To test the efficacy of CP-751,871 combined with exemestane in the treatment of postmenopausal patients with hormone positive advanced breast cancer

NCT ID: NCT00366795 Terminated - Liver Cirrhosis Clinical Trials

Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver

SPARe-2
Start date: August 2006
Phase: Phase 3
Study type: Interventional

Primary: To evaluate the efficacy of satavaptan in the absence of concomitant diuretic drugs in reducing the recurrence of ascites. Secondary: To evaluate the tolerability and safety of satavaptan in the absence of concomitant diuretic drugs over a 52-week treatment period in patients with cirrhosis of the liver and recurrent ascites. The one-year double blind placebo controlled period is extended up to 2 years in a long term safety study (PASCCAL-2).

NCT ID: NCT00362388 Terminated - Clinical trials for Coronary Artery Disease

Cell Therapy in Chronic Ischemic Heart Disease

Start date: January 2006
Phase: Phase 3
Study type: Interventional

This study was designed to test the hypothesis that direct injection of bone-marrow cells in the heart may increase the number of blood vessels, ameliorating the heart's performance, and relieving patients from symptoms like angina and/or shortness of breath.

NCT ID: NCT00356525 Terminated - Lung Neoplasms Clinical Trials

Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor

Start date: September 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to help answer: - Whether pemetrexed, gemcitabine and/or carboplatin can shrink tumor(s) or make tumor(s) disappear in patients with relapsed lung cancer (lung cancer that has come back after surgical removal and chemotherapy), and to determine how long this will last - Whether pemetrexed, gemcitabine and/or carboplatin can help patients with relapsed lung cancer live longer

NCT ID: NCT00353743 Terminated - Abortion, Septic Clinical Trials

The Use of Antibiotics After Hospital Discharge in Septic Abortion

APA
Start date: May 2006
Phase: N/A
Study type: Interventional

The use of antibiotics in post-partum infection has been abbreviated. After 48 hours of clinical improvement, the patient is discharged from the hospital without antibiotics. No trials has been found in cases of septic abortion. The purpose of the present study is to verify the need of antibiotics after clinical improvement in cases of septic abortion.

NCT ID: NCT00353574 Terminated - Hypertension Clinical Trials

DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension

Darusentan
Start date: September 2006
Phase: Phase 3
Study type: Interventional

This is a research study of a new experimental drug called darusentan. Darusentan is not currently approved by the United States (U.S.) Food and Drug Administration (FDA) for use in the U.S., which means that a doctor cannot prescribe this drug. The purpose of this study is to evaluate the long-term safety of darusentan in subjects with resistant systolic hypertension despite treatment with full doses of three or more antihypertensive medications, including a diuretic.